[Clinical significance of molecular genetic markers in malignant lymphomas]. 1987

G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005803 Genes, Immunoglobulin Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity). Genes, Ig,Immunoglobulin Genes,Gene, Ig,Gene, Immunoglobulin,Ig Gene,Ig Genes,Immunoglobulin Gene
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
April 2010, Current protocols in human genetics,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
April 2017, Current protocols in human genetics,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
September 1981, Therapeutische Umschau. Revue therapeutique,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
April 1998, Blood,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
January 1998, Annals of surgical oncology,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
January 1991, Pediatric neurosurgery,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
January 1991, Scandinavian journal of clinical and laboratory investigation. Supplementum,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
July 1982, European journal of cancer & clinical oncology,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
November 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
G Krieger, and M Kneba, and M Bergholz, and I Bolz, and M Hulpke, and G A Nagel
September 1988, Journal of virological methods,
Copied contents to your clipboard!